Plasma Concentrations of Efavirenz with a 600 Mg Standard Dose in Cambodian HIV-Infected Adults Treated for Tuberculosis with a Body Weight above 50 Kg

The current WHO guidelines recommending 600 mg efavirenz daily irrespective of patient's body weight remains a safe and effective approach to treating coinfected adults needing simultaneous tuberculosis and HIV therapy.